Form 4: Qualys Director Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Qualys, Inc. Director Wendy Pfeiffer sold 200 shares of common stock for $138.78 per share on June 13, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Wendy Pfeiffer, a Director of Qualys, Inc. (QLYS), reported a sale of common stock.
- The transaction occurred on June 13, 2025.
- She sold 200 shares at a price of $138.78 per share.
- Following this transaction, Ms. Pfeiffer directly owns 11,482 shares of Qualys common stock.
- The sale was executed under a Rule 10b5-1 trading plan, which was adopted on February 21, 2025.
Sentiment
Score: 5
Explanation: Neutral. The sale is a routine transaction under a pre-arranged 10b5-1 plan, which mitigates negative sentiment typically associated with insider selling.
Negatives
- A director, Wendy Pfeiffer, sold 200 shares of common stock. While a small amount and part of a pre-arranged plan, insider selling can sometimes be perceived with slight caution by the market.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May view insider selling with slight caution, though the execution under a Rule 10b5-1 plan suggests a pre-planned, non-discretionary sale, which typically reduces concerns about the company's immediate prospects.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Date Rule 10b5-1 trading plan was adopted by Wendy Pfeiffer. |
| 06/13/2025 | Date of common stock sale by Wendy Pfeiffer. |
| 06/16/2025 | Date Form 4 was signed. |
Keywords
Qualys, QLYS, Insider Trading, Form 4, Stock Sale, Director, Wendy Pfeiffer, Rule 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.